A systematic review on the role of stem cells in the treatment and diagnosis of neurological diseases such as MS in overweighting patients with endoscopy point

Abstract

Currently, the role of stem cells in the treatment and diagnosis of neurological diseases such as Alzheimer's and MS have been systematically investigated. Alzheimer's disease (AD) is the most common dementia in the elderly population. Alzheimer's disease is a permanent and progressive brain disorder that causes heavy social and financial losses worldwide. In a recent study, the topic was investigated by reviewing more than 80 articles and searching for the keywords "stem cells", "neurological diseases", "Alzheimer's" and "MS". The results of a recent study on MS patients showed that current treatments for AD patients can only reduce symptoms, but cannot completely prevent neurodegeneration. Therefore, there is no long-term improvement. Stem cells are undifferentiated cells that have the ability to produce many different types of cells in the body. A large amount of data shows the therapeutic potential of stem cells for a variety of neurological diseases. Numerous studies have shown that neuronal and glial cells have been successfully differentiated from various stem cells. The results of a recent study have shown that the progenitors of nerve cells that enter the body in this way migrate to the brain and settle especially in the white matter of the brain. Also, regarding MS disease, about 80% of the patients have not relapsed after 2 years of treatment. While stem cell therapy in MS is often associated with severe side effects, no patients died and the procedure was deemed safe. Therefore, treatment of this highly active type of MS with stem cells may be better than some  DMT-modulating treatments. Disease-modifying therapy (DMT) is used as an approach to disease control. This treatment helps slow the progression of the disease.